Zydelig
My Prescription
Payment
Select pharmacy
$15,989.16
Print or send this coupon to your phone
AlbertsonsPowered byAbout Zydelig
Drug Details
Idelalisib is prescribed for the treatment of chronic lymphocytic leukemia (CLL), a specific type of cancer. As a kinase inhibitor, this medication functions by inhibiting the growth and proliferation of cancer cells.
Price history for Zydelig
60 Tablets, 100MG
Average retail price for Zydelig
Average SaveHealth price for Zydelig
Our price history data is based on aggregated prescription data collected from participating pharmacies in America. Our prescription data updates daily to reflect the latest price changes. If you notice a missing data point, it means there wasn't sufficient data available to generate a monetary value for that date.
*Retail prices are based on pharmacy claims data, and may not be accurate when we don't have enough claims.
Zydelig dosage forms
| Dosage | Quantity | Price from | Per unit |
|---|---|---|---|
| 100MG | 60 Tablets | $15,989.16 | $266.49 |
| 150MG | 60 Tablets | $15,989.16 | $266.49 |
Zydelig FAQs
Zydelig is used for the treatment of certain types of blood cancers, specifically chronic lymphocytic leukemia (CLL), follicular B-cell non-Hodgkin lymphoma (FL), and small lymphocytic lymphoma (SLL). It is typically prescribed for patients who have received at least one prior therapy.
Yes, Zydelig (idelalisib) is still on the market. It is used for the treatment of certain types of blood cancers. However, it is important for patients to discuss with their healthcare provider about its use, as it may have specific indications and potential side effects.
Zydelig (idelalisib) is not classified as traditional chemotherapy. It is an oral medication that belongs to a class of drugs known as kinase inhibitors. It specifically targets certain proteins involved in the growth and survival of cancer cells, making it a targeted therapy rather than conventional chemotherapy.
The cost of Zydelig can vary based on factors such as the pharmacy, location, insurance coverage, and dosage. It is recommended to contact a local pharmacy or healthcare provider for the most accurate and up-to-date pricing information. Additionally, patients may explore patient assistance programs or insurance plans that could help reduce the cost.
Idelalisib is used for the treatment of certain types of blood cancers, including chronic lymphocytic leukemia (CLL), follicular B-cell non-Hodgkin lymphoma, and small lymphocytic lymphoma (SLL). It is typically used in patients who have received prior therapies.